Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors

Neuroscience

Volumn 152, Issue 4, 2008, Pages 1110-1118

  Oliveira, M S ^a,b   Furian, A F ^a,b   Rambo, L M ^a   Ribeiro, L R ^a   Royes, L F F ^a   Ferreira, J ^a   Calixto, J B ^c   Mello, C F ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

EEG; epilepsy; PGE2; PTZ; rat

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; BUTAPROST; L 161982; L 826266; PENTETRAZOLE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; ELECTROGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; MALE; PENTYLENETETRAZOLE; PROSTAGLANDIN ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; SEIZURES;

EID: 41549132023     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.01.005     Document Type: Article

References (38)

1. Ahmad A.S., Ahmad M., de Brum-Fernandes A.J., and Dore S. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 1066 (2005) 71-77
2. Ahmad A.S., Saleem S., Ahmad M., and Dore S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89 (2006) 265-270
3. Ahmad A.S., Zhuang H., Echeverria V., and Dore S. Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity. J Neurotrauma 23 (2006) 1895-1903
4. Ahmad M., Ahmad A.S., Zhuang H., Maruyama T., Narumiya S., and Dore S. Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury. J Neuroimmunol 184 (2007) 172-179
5. Akarsu E.S., Ozdayi S., Algan E., and Ulupinar F. The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: possible role of cyclooxygenase-2 induction. Epilepsy Res 71 (2006) 181-187
6. Andre V., Pineau N., Motte J.E., Marescaux C., and Nehlig A. Mapping of neuronal networks underlying generalized seizures induced by increasing doses of pentylenetetrazol in the immature and adult rat: a c-Fos immunohistochemical study. Eur J Neurosci 10 (1998) 2094-2106
7. Bazan N.G., Tu B., and Rodriguez de Turco E.B. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. Prog Brain Res 135 (2002) 175-185
8. Boie Y., Stocco R., Sawyer N., Slipetz D.M., Ungrin M.D., Neuschafer-Rube F., Puschel G.P., Metters K.M., and Abramovitz M. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol 340 (1997) 227-241
9. Carlson N.G. Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid. J Neurosci Res 71 (2003) 79-88
10. Cernak I., O'Connor C., and Vink R. Activation of cyclo-oxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats. Clin Exp Pharmacol Physiol 28 (2001) 922-925
11. Desjardins P., Sauvageau A., Bouthillier A., Navarro D., Hazell A.S., Rose C., and Butterworth R.F. Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis. Neurochem Int 42 (2003) 299-303
12. Dhir A., Naidu P.S., and Kulkarni S.K. Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1478-1485
13. Dore S. GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE2 EP1 receptor. Trends Pharmacol Sci 27 (2006) 458-460
14. Echeverria V., Clerman A., and Dore S. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure. Eur J Neurosci 22 (2005) 2199-2206
15. Ferraro T.N., Golden G.T., Smith G.G., St Jean P., Schork N.J., Mulholland N., Ballas C., Schill J., Buono R.J., and Berrettini W.H. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 19 (1999) 6733-6739
16. FitzGerald G.A. COX-2 and beyond: Approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2 (2003) 879-890
17. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., Kunz A., Cho S., Orio M., and Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12 (2006) 225-229
18. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., and Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am J Pathol 155 (1999) 995-1004
19. Liang X., Wang Q., Hand T., Wu L., Breyer R.M., Montine T.J., and Andreasson K. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J Neurosci 25 (2005) 10180-10187
20. Machwate M., Harada S., Leu C.T., Seedor G., Labelle M., Gallant M., Hutchins S., Lachance N., Sawyer N., Slipetz D., Metters K.M., Rodan S.B., Young R., and Rodan G.A. Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol 60 (2001) 36-41
21. Manabe Y., Anrather J., Kawano T., Niwa K., Zhou P., Ross M.E., and Iadecola C. Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity. Ann Neurol 55 (2004) 668-675
22. McColl C.D., Horne M.K., Finkelstein D.I., Wong J.Y., Berkovic S.F., and Drago J. Electroencephalographic characterisation of pentylenetetrazole-induced seizures in mice lacking the alpha 4 subunit of the neuronal nicotinic receptor. Neuropharmacology 44 (2003) 234-243
23. McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R.M., and Andreasson K. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24 (2004) 257-268
24. Melnikova T., Savonenko A., Wang Q., Liang X., Hand T., Wu L., Kaufmann W.E., Vehmas A., and Andreasson K.I. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience 141 (2006) 1149-1162
25. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., Isakson P.C., Chen J., and Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci U S A 95 (1998) 10954-10959
26. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193-1226
27. Okada K., Yuhi T., Tsuji S., and Yamashita U. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible E1 mice was increased after seizure. Brain Res 894 (2001) 332-335
28. Oliveira M.S., Furian A.F., Royes L.F.F., Fighera M.R., Fiorenza N.G., Castelli M., Machado P., Bohrer D., Veiga M., Ferreira J., Cavalheiro E.A., and Mello C.F. Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res (2008) doi:10.1016/j.eplepsyres.2007.12.008.
29. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, San Diego
30. Sang N., and Chen C. Lipid signaling and synaptic plasticity. Neuroscientist 12 (2006) 425-434
31. Shafiq N., Malhotra S., and Pandhi P. Anticonvulsant action of celecoxib (alone and in combination with sub-threshold dose of phenytoin) in electroshock induced convulsion. Methods Find Exp Clin Pharmacol 25 (2003) 87-90
32. Simmons D.L., Botting R.M., and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56 (2004) 387-437
33. Sugimoto Y., and Narumiya S. Prostaglandin E receptors. J Biol Chem 282 (2007) 11613-11617
34. Topol E.J., and Falk G.W. A coxib a day won't keep the doctor away. Lancet 364 (2004) 639-640
35. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38 (1998) 97-120
36. Vezzani A., and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46 (2005) 1724-1743
37. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., and Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 97 (2000) 11534-11539
38. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386